Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.72 |
| ▸ | ATM | Q13315 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA9 | Q16790 | 4/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ornidazole SCHEMBL15158378 | 1.00 | CHRM1 (1.00) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL15158379 | 1.00 | CHRM1 (1.00) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL28751635 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL27852176 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL28196949 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL29083057 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL28736392 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL29044809 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL22773516 | 0.99 | CHRM1 (0.97) | CHRM1MAPK1ATMALDH1A1LMNA | |
| Ornidazole SCHEMBL22773563 | 0.97 | CHRM1 (0.95) | CHRM1MAPK1ATMALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6679 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119349776-B | Microorganism-loaded activated carbon composition, nitrile-containing wastewater pretreatment process and device | 南京环保产业创新中心有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12544444-B2 | Administration of tailored feedstock to increase antibiotic susceptibility | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2026-02-10 | — | — | US | claimed |
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| EP-4680248-A1 | PRODUCTS OF MANUFACTURE AND THERAPEUTIC COMPOSITIONS FOR TREATING, AMELIORATING OR PREVENTING VIRAL INFECTIONS AND METHODS FOR MAKING AND USING THEM | Topelia Aust Limited (ACN 652 771 670) (AU) | 2026-01-21 | — | — | EP | claimed |
| US-20260014216-A1 | USE OF PROBIOTIC COMPOSITION IN PREPARATION OF FORMULATION FOR IMPROVING VAGINAL HEALTH | SICHUAN ANAEROBIC BIOTECHNOLOGY CO LTD (CN) | 2026-01-15 | — | — | US | claimed |
| EP-4658376-A1 | SKIN CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2025-12-10 | — | — | EP | claimed |
| WO-2025237916-A1 | BIOMATERIAL COMPOSITION COMPRISING A POLYHYDROXYBUTYRATE IN PARTICULATE FORM | LABORATOIRES VIVACY (FR) | 2025-11-20 | — | — | WO | claimed |
| US-20250346910-A1 | METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION | COMMENSE BIO INC (US) | 2025-11-13 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| WO-1999030693-A2 | A DOUBLE CAPSULE FOR THE ADMINISTRATION OF ACTIVE PRINCIPLES IN MULTIPLE THERAPIES | AXCAN PHARMA INC. (CA) | 1999-06-24 | — | — | WO | claimed |
| WO-1999025347-A2 | CHEMICAL COMPOUNDS HAVING ION CHANNEL BLOCKING ACTIVITY FOR THE TREATMENT OF IMMUNE DYSFUNCTION | NEUROSEARCH A/S (DK) | 1999-05-27 | — | — | WO | claimed |
| EP-0910348-A1 | LOCALLY ADMINISTRABLE, BIODEGRADABLE AND SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR PERIODONTITIS AND PROCESS FOR PREPARATION THEREOF | Samyang Corporation (KR) | 1999-04-28 | — | — | EP | claimed |
| WO-1999012548-A1 | TREATMENT OF INFLAMMATORY CONDITIONS | THERAMARK LIMITED (GB) | 1999-03-18 | — | — | WO | claimed |
| WO-1999012547-A1 | TREATMENT OF INFLAMMATORY CONDITIONS | THERAMARK LIMITED (GB) | 1999-03-18 | — | — | WO | claimed |
| CN-1205207-A | Nitra-bismuth-zole | JIANG ENRONG (CN) | 1999-01-20 | — | — | CN | claimed |
| WO-1997044016-A1 | LOCALLY ADMINISTRABLE, BIODEGRADABLE AND SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR PERIODONTITIS AND PROCESS FOR PREPARATION THEREOF | SAMYANG CORPORATION (KR) | 1997-11-27 | — | — | WO | claimed |
| US-5273992-A | Administering one of a class of compounds of N-imidazole and N-nitroimidazole derivatives; inhibition of the calcium-activated potassium channels at the membranes | BETH ISRAEL HOSPITAL ASSOC. INC. (US) | 1993-12-28 | — | — | US | claimed |
| EP-0304374-B1 | THERAPEUTICAL PREPARATION CONTAINING COLLAGEN AND IMIDAZOLE DERIVATIVES | SEPTODONT (FR) | 1992-01-08 | — | — | EP | claimed |
| US-4183941-A | Treatment of rheumatoid arthritis and related diseases | Simoons, John R. A. (US) | 1980-01-15 | — | — | US | claimed |